Isolator Synergy Clamps

The FIRST and ONLY Approved Surgical Device to Treat Atrial Fibrillation

Product Code(s)

  • OLL2
  • OSL2

The Isolator Synergy ablation clamp is the FIRST and ONLY surgical ablation device offered with FDA approval for the treatment of Atrial Fibrillation (Afib) and the only device either Catheter or Surgical to be approved for the treatment of persistent and long-standing persistent  Afib.

The AtriCure Synergy Ablation System is intended to ablate cardiac tissue for the treatment of persistent atrial fibrillation (sustained beyond seven days, or lasting less than seven days but necessitating pharmacologic or electrical cardioversion) or longstanding persistent atrial fibrillation (continuous atrial fibrillation of greater than one year duration) in patients who are undergoing open concomitant coronary artery bypass grafting and/or valve replacement or repair.

Instructions for Use

Download Product Brochure

View PMA approval letter

This notice is provided to satisfy the virtual patent marking provisions under 35 USC § 287(a), these devices are protected by U.S. Patent No. 7,001,415 and other patents pending.